| Advantages | They are ideal for disease modeling, drug testing, and investigating skin responses to treatments. Compared to traditional 2D cultures, these organoids offer a more accurate representation of human skin, advancing dermatology and cosmetic research. |
| Species | Human |
| Product Type | Tissue-derived Organoid |
| Growth Properties | Embedded 3D Culture |
| Growth Conditions | Cultured at 37°C under 95% air and 5% CO2. |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Epidermal/Epidermis |
| Disease | Normal |
| Format | Frozen |
| Organoid Characterization | They recapitulate key features of the epidermis, including keratinocyte organization, dermal-epidermal junctions, and stratum corneum formation. These organoids provide a physiologically relevant platform for studying skin development, wound healing, and epidermal diseases such as psoriasis and eczema. |
| Applications | Tissue-derived organoids are widely utilized in drug screening, disease modeling, mechanistic studies, personalized medicine, and regenerative medicine. By accurately modeling disease states, they provide a robust platform for evaluating patient-specific drug responses and supporting individualized treatment planning. Moreover, these organoids enable the development of new therapeutic modalities, particularly in cancer research and tissue regeneration, delivering precise experimental systems that significantly advance precision medicine. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.